ASOK K Dasmahapatra

Dr. ASOK K Dasmahapatra

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2011 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
SKShabana I. Khan
Shabana I. Khan
PAPranapda Aumsuwan
Pranapda Aumsuwan
IKIkhlas A. Khan
Ikhlas A. Khan
LWLarry A. Walker
Larry A. Walker
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra

1 February 2016 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
PAPranapda Aumsuwan
Pranapda Aumsuwan
SKShabana I. Khan
Shabana I. Khan
IKIkhlas A. Khan
Ikhlas A. Khan
ZAZulfiqar Ali
Zulfiqar Ali
BABharathi Avula
Bharathi Avula
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra

21 June 2011 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
SKShabana Iqrar Khan
Shabana Iqrar Khan
JZJianping Zhao
Jianping Zhao
IKIkhlas Khan
Ikhlas Khan
LWLarry A Walker
Larry A Walker
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra
Aromatase, the key enzyme in estrogen biosynthesis, converts androstenedione to estrone and testosterone to estradiol. The enzyme is expressed in various tissues such as ovary, placenta, bone, brain, skin, and adipose tissue. Aromatase enzyme is encoded by a single geneCYP 19A1and its expression is controlled by tissue-specific promoters. Aromatase mRNA is primarily transcribed from promoter I.4 in normal breast tissue and physiological levels of aromatase are found in breast adipose stromal fibroblasts. Under the conditions of breast cancer, as a result of the activation of a distinct set of aromatase promoters (I.3, II, and I.7) aromatase expression is enhanced leading to local overproduction of estrogen that promotes breast cancer. Aromatase is considered as a potential target for endocrine treatment of breast cancer but due to nonspecific reduction of aromatase activity in other tissues, aromatase inhibitors (AIs) are associated with undesirable side effects such as bone loss, and abnormal lipid metabolism. Inhibition of aromatase expression by inactivating breast tumor-specific aromatase promoters can selectively block estrogen production at the tumor site. Although several synthetic chemical compounds and nuclear receptor ligands are known to inhibit the activity of the tumor-specific aromatase promoters, further development of more specific and efficacious drugs without adverse effects is still warranted. Plants are rich in chemopreventive agents that have a great potential to be used in chemotherapy for hormone dependent breast cancer which could serve as a source for natural AIs. In this brief review, we summarize the studies on phytochemicals such as biochanin A, genistein, quercetin, isoliquiritigenin, resveratrol, and grape seed extracts related to their effect on the activation of breast cancer-associated aromatase promoters and discuss their aromatase inhibitory potential to be used as safer chemotherapeutic agents for specific hormone-dependent breast cancer.

22 February 2006 in Birth Defects Research Part B: Developmental and Reproductive Toxicology
Verified
Journal Article
Open access
PDF file
XWXueqing Wang
Xueqing Wang
EWErin Williams
Erin Williams
MHMary L. Haasch
Mary L. Haasch
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra
BACKGROUND: Animal models are necessary to investigate the mechanism of alcohol-induced birth defects. We have used Japanese medaka (Oryzias latipes) as a non-mammalian model to elucidate the molecular mechanism(s) of ethanol teratogenesis. METHODS: Medaka eggs, within 1 hr post-fertilization (hpf) were exposed to waterborne ethanol (0–1000 mM) in hatching solution for 48 hr. Embryo development was observed daily until 10 days post-fertilization (dpf). The concentration of embryonic ethanol was determined enzymatically. Cartilage and bones were stained by Alcian blue and calcein, respectively and skeletal and cardiovascular defects were assessed microscopically. Genetic gender of the embryos was determined by PCR. Levels of two isoenzymes of alcohol dehydrogenase (Adh) mRNAs were determined by semi-quantitative and real-time RT-PCR. RESULTS: The concentration of ethanol required to cause 50% mortality (LC50) in 10 dpf embryos was 568 mM, however, the embryo absorbed only 15–20% of the waterborne ethanol at all ethanol concentrations. The length of the lower jaw and calcification in tail fin cartilaginous structures were reduced by ethanol exposure. Active blood circulation was exhibited at 50+ hpf in embryos treated with 0–100 mM ethanol; active circulation was delayed and blood clots developed in embryos treated with 200–400 mM ethanol. The deleterious effects of ethanol were not gender-specific. Moreover, ethanol treatment was unable to alter the constitutive expression of either Adh5 or Adh8 mRNA in the medaka embryo. CONCLUSIONS: Preliminary results suggested that embryogenesis in medaka was significantly affected by ethanol exposure. Phenotypic features normally associated with ethanol exposure were similar to that observed in mammalian models of fetal alcohol syndrome. The results further indicated that medaka embryogenesis might be used as an alternative non-mammalian model for investigating specific alterations in gene expression as a means to understand the molecular mechanism(s) of ethanol-induced birth defects. Birth Defects Res (Part B) 77:29–39, 2006.

30 May 2025 in Frontiers in Toxicology
Verified
Journal Article
Open access
PDF file
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra
JCJoydeep Chatterjee
Joydeep Chatterjee
Paul B TchounwouPaul B Tchounwou
Paul B Tchounwou
The global concern about plastics has been amplified due to their widespread contamination in the environment and their ability to cross biological barriers in living organisms. However, our understanding of their bioaccumulation, toxicity, and interaction with other environmental pollutants remains limited. Plastics are classified into three categories: macro-(MAP > 5 mm), micro-(MIP, <5 mm), and nanoplastics (NAP≤ 100 nm). Among these, NAPs have superior sorption capacity, a large surface area, and a greater ability to release co-contaminants into tissues, resulting in more complex and harmful effects compared to MAPs and MIPs. To assess the toxic effects of NAPs, particularly their genotoxicity in fish, we carried out a bibliographic search in PubMed using the search terms “nanoplastics” and “fish,” which yielded 233 articles. These studies focused on various polymers including polyamide (PA), polycarbonate (PC), polyethylene (PE), polyethylene terephthalate (PET), polymethylmethacrylate (PMMA), polypropylene (PPP), polystyrene (PS), and polyvinyl chloride (PVC). We further refined our search by including fish species such as common carp, fathead minnows, medaka, tilapia, trout, and zebrafish and selected 114 articles for review. This article provides a comprehensive overview of the current state of knowledge on the effects of NAPs on fishes, emphasizing their interaction with co-contaminants including metals, polycyclic aromatic hydrocarbons, pharmaceuticals, pesticides, antibiotics, plastic additives, and endocrine disruptors found in the aquatic environments. Our findings indicate that among fish species, zebrafish (∼68%) is the most frequently studied, while PS (∼89%) is the most commonly encountered NAP in the aquatic ecosystems. Despite substantial experimental variability, our systematic review highlights that NAPs accumulate in various tissues of fish including the skin, muscle, gill, gut, liver, heart, gonads, and brain across all developmental stages, from embryos to adults. NAP exposure leads to significant adverse effects including increased oxidative stress, decreased locomotor and foraging activities, altered growth, immunity, lipid metabolism, and induced neurotoxicity. Furthermore, NAP exposure modulates estrogen–androgen–thyroid–steroidogenesis (EATS) pathways and shows potential intergenerational effects. Although the USEPA and EU are aware of the global impacts of plastic pollution, the prolonged persistence of plastics continues to pose a significant risk to both aquatic life and human health.

1 October 2015 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
ASOK K DasmahapatraASOK K Dasmahapatra
ASOK K Dasmahapatra
IKIkhlas A. Khan
Ikhlas A. Khan